Sun Pharma's shares are in the spotlight as the company announced on Saturday that a U.S. court has issued a preliminary injunction preventing the launch of ...

Prabhudas Lilladher is positive on Sun Pharmaceutical Industries and has given a buy rating with a target price of Rs 1885 in their research report dated ...

On Friday, Sun Pharma announced that the US Food and Drug Administration (FDA) approved their new drug, Leqselvi (deuruxolitinib) 8 mg tablets, for treating ...